We report a 23-year-old man with XH who presented with cluster type headache, diabetes insipidus and MRI-proven pituitary intrasellar mass. Since 2009 our patient suffered from recurrent headache. CT scan, ophthalmological, neurological investigations revealed no obvious cause of the symptoms. In April 2011, polyuria-polydipsia occurred and endrocrine investigations revealed diabetes insipidus. Anterior pituitary hormone levels were normal: TSH: 1.3 mIU/l, FSH: 2.4 IU/l, LH: 3.7 IU/l, PR L: 197 mIU/l, ACTH: 7.78 pm/l, cortisol 08 h: 444 nm/l. After initialization of ddAVP treatment, diuresis returned to normal. The pituitary MRI scan revealed a 14x10x17 mm inhomogenous lesion with the disappearance of the hyperintense signal of the neurohypophysis. In July 2011, transsphenoideal surgery was performed and histology proved xanthomatous hypophysitis. We could stop the glucocorticoid (GC) treatment without having any perioperative complication. The headache resolved but the diabetes insipidus persisted. The anterior pituitary function after the surgery was normal: serum cortisol 08 h: 404-445 nm/l, ACTH:6.49 pm/l, FSH:3.1 mIU/l, LH:4.2 mIU/l, TSH:1.61 mIU/l. 2 months later severe cluster type headache occurred. Endocrine investigations revealed hypadrenia, hypothyroidism and peripheral hypogonadism: serum cortisol 08 h: 96 nm/l, TSH: 1.32 mIU/l, ft4: 10.5 pm/l, testosterone: 3.44 nm/l, FSH: 3.3 mIU/l, LH: 2.8 mIU/l, ACTH: 3.38pm/l. LHRH test results: FSH: 0 min: 2.8, 30 min: 4.7, 60 min: 5.1 mIU/l, LH: 0 min: 2.9, 30 min:13.5, 60 min:13.8 mIU/l. The postopreative pituitary MRI scan proved the persistent presence of the inhomogenous mass. After initialization of glucocorticoid replacement the headache disappeared. With levothyroxin, testosterone supplementation and gradually lowered dosage of GC and all symptomps disappeared with the exception of diabetes insipidus. Despite of low IGF 1 (92 ng/ml,age matched reference rate:117-329 ng/ml) and hGH (0.08 ng/ml) levels GH therapy was not introduced. Autoimmune screen: ANA, antiCL, antib2GP, antitransglutaminase, antiTPO and antiparietal cell antibody was negative. Regularly performed sella MRI scans showed no change in tumor size and appearance after the surgery and after the introduction of hormone replacement therapy.
